Raised more than $430 million in gross proceeds during 2019, funding operations for at least the next three years Initiated a Phase 1b clinical trial to evaluate the safety and tolerability of KarXT ...

Upon the closing of the Consumer Healthcare JV transaction(1) in third-quarter 2019, Pfizer deconsolidated its Consumer Healthcare segment, which resulted in a shift from recording revenue and expense ...

Represents the add-back to operating income driven by the hypothetical interest expense we would incur if the property under our operating leases were owned or accounted for as finance leases.

IBM's revenue declined in 2019. It marked the sixth time in the last eight years Big Blue posted a year-over-year decrease. But, the Armonk-based company is touting continued growth of its cloud ...

Tesla Inc. lost $775 million in 2019, a 27% improvement from the year prior, after it sold a record number of vehicles. The Silicon Valley electric-car maker delivered a record of about 112,000 ...